Amniotic fluid embolism

Last updated
Amniotic fluid embolism
Amniotic fluid embolism.jpg
Intravascular squames are present in this example of amniotic fluid embolism.
Specialty Obstetrics   OOjs UI icon edit-ltr-progressive.svg
Risk factors Advanced maternal age, history of pre-eclampsia, uterine rupture, fetal distress
Frequency1 in 20,000 births
Pathophysiology of the amniotic fluid embolism Amniotic fluid embolism.png
Pathophysiology of the amniotic fluid embolism

An amniotic fluid embolism (AFE) is a life-threatening childbirth (obstetric) emergency in which amniotic fluid enters the blood stream of the mother, triggering a serious reaction which results in cardiorespiratory (heart and lung) collapse and massive bleeding (coagulopathy). [1] [2] [3] The rate at which it occurs is 1 instance per 20,000 births and it comprises 10% of all maternal deaths.

Contents

Signs and symptoms

Amniotic fluid embolism is suspected when a woman giving birth experiences very sudden insufficient oxygen to body tissues, low blood pressure, and profuse bleeding due to defects in blood coagulation.

The signs and symptoms of amniotic fluid embolism can vary from one individual to another but involve systemic involvement of multiple organ systems. Often, a patient may present with a cough due to the release of bradykinin, an inflammatory marker released during times of pain and which causes an anaphylactoid reaction. [4] The cough may then progress to dyspnea and shortness of breath or difficulty breathing due to the vasoconstriction of the pulmonary arterioles making it more difficult for air to flow through. [4] [5] This decreased air flow will lead to the decrease of oxygen being delivered to the tissues to offload carbon dioxide from the blood. The heart will try to compensate by speeding up and causing tachycardia or a fast heart rate in the mother. The fetus will respond to the changes in the mother if still in labor by exhibiting tachycardia and decelerations in the fetal heart rate tracing. It will then register as a low pulse oximetry reading when performed by the health care staff and will result in hypoxia. [5]

Most commonly patients will experience hypotension or low blood pressure due to the widespread inflammation and anaphylaxis occurring. [5]

As the amniotic fluid builds up in the lungs, the patient may begin to exhibit signs of pulmonary hypertension due to the fluid blocking the blood flow of the lungs and decreasing the oxygen. [4] As the amniotic fluid embolism progresses the final stage before cardiovascular collapse involves hemorrhaging or large volume blood loss. [5] This leads to the over activation of the coagulation cascade creating an over production of blood clots with the inability to be broken down resulting in DIC or Disseminated Intravascular Coagulation. [4] [5]

Causes and pathophysiology

There are several posited ways that have been positioned to cause amniotic fluid embolism. The first of which involves the thought that a combination or one of the following that include a difficult labor, a placenta that is abnormal and trauma to the abdomen through a caesarean section or other surgical tools dissipates the barrier that exists from the maternal fluid to the fetal fluid. [5] [6] The disruption then causes a buildup of hydrostatic pressures and oncotic pressures leaking the fetal fluid into the maternal circulation. [5] [7] This fluid is then carried through the veins to the superior vena cava to the right atrium and on to the right ventricle eventually entering the pulmonary artery and disseminating through the pulmonary circuit. [5] [7] This causes the fluid of the alveoli of the lungs to build up and cause increased pressures that put extra work on the heart. This leads to pulmonary hypertension causing right ventricular heart failure which leads to cardiovascular collapse. [5] [7] [6]

The second school of thought is that a series of inflammatory markers in amniotic fluid causes a widespread inflammatory activation in the blood throughout the maternal circulation. [5] [7] This causes intense pulmonary vasospasm leading to dysregulation of the pulmonary circulation causing failure in the systemic circulation.

Furthermore, amniotic fluid contains further elements such as tissue factor and other clotting factors that lead to a hypercoagulable state or consistent development and formation of blood clots in the body with the inability to be broken down. [4] This leads to the sequelae of DIC or Disseminated intravascular coagulation. [5] [7]

It is also supposed that endothelin a potent vasoconstrictor is upregulated during the course of the amniotic fluid embolism in the maternal circulation. This endothelin acts in an antagonistic fashion to blood vessels causing intense vasoconstriction. [5] This leads to super tight vessels that cut off the blood supply to the lungs and heart resulting in cardiorespiratory collapse. [5] [7]

Risk factors

The occurrence of amniotic fluid embolism is not readily defined as it is a spontaneous event and has not set progression. However, it is most known to occur alongside a cesarean section delivery, a difficult vaginal birth and hours after delivery has been completed. [5] [8]

Some risk factors for amniotic fluid embolism include:

The method by which labor is induced seemingly plays a role in the risk for amniotic fluid embolism as well. [4] Induction with vaginal prostaglandin E2 was seen as significantly increasing the relative risk for the emergence of amniotic fluid embolism on a laboring mother. [5] [4]

Overall, however, any method of induction for labor including surgical induction, artificial rupture of membranes or oxytocin is seen as increasing the risk of amniotic fluid embolism in labor. [4]

Male fetuses and fetuses of low birth rate also present a great risk to mothers. [7]

Diagnosis

In order to diagnose amniotic fluid embolism, there are a few important factors that must be present:

  1. Hypoxia [8] [5] [7]
  2. Hypotension [5] [6] [7]
  3. Acutely severe hemorrhage [5] [7] [6]
  4. Occurs during labor or up to 30 minutes after labor [5]

In order to diagnose an amniotic fluid embolism, an arterial blood gas (ABG) must be taken immediately to determine the acid-base status. The ABG should demonstrate a low PH and increased PCO2 levels consistent with a respiratory acidosis. Continuous pulse oximetry readings as well will determine the level of hypoxia and what the oxygen requirements are. [5]

Coagulation studies should also be collected. Special attention should be paid to the PT (prothrombin time) and the PTT (partial thromboplastin time). If coagulation factors are being used, the PT will be prolonged and the PTT may be normal or prolonged. [5] [4]

A type and screen should also be ordered in case there needs to be blood products transfused in the event of an hemorrhage. [5]

Biomarkers

There are several biomarkers that are said to be able to determine if AFE will occur or has occurred, including: [5] [4] [8]

Treatment and management

When dealing with a patient with amniotic fluid embolism, stabilizing the patient is the first line of action. If the patient is in need of oxygen, oxygen delivered via a high flow rebreather mask should be given. If a patient is unstable and unable to receive oxygen via the high flow rebreather mask or nasal cannula, then steps should be taken to support the patient via endotracheal tube and placed on a ventilator. [8] [6]

A patient at risk of cardiovascular compromise due to late stage vasodilation of the blood vessels should be given phenylephrine to vasoconstrict the arteries and raise the blood pressure to prevent persistent hypotension [8] Due to the nature of AFE being an anaphylaxis like reaction epinephrine should be given as well. [5] [7] [8]

If hemorrhage occurs, the transfusion of packed blood red cells is given promptly to prevent further complications. [5] [7] In the case of DIC, recombinant activated factor VIIa is quick way to address this issue. Serine proteinase inhibitor FOY and Aprotinin have also been used to treat DIC in AFE. [8]

A case report on Amniotic Fluid Embolism published in the A & A Practice Journal in 2020 has revealed that when milrinone is administered as an aerosol, selective pulmonary vasodilation occurs without significant changes [9] in mean arterial pressure or systemic vascular resistance; and if used immediately after Amniotic Fluid Embolism, inhaled milrinone may mitigate the pulmonary vasoconstriction. [10] [11]

Epidemiology

Amniotic fluid embolism is very uncommon and the rate at which it occurs is 1 instance per 20,000 births. Though rare, it comprises 10% of all maternal deaths. [2]

History

This rare complication has been recorded seventeen times prior to 1950. The complication was originally described in 1926 by J. R. Meyer at the University of São Paulo. [12] [13] A 1941 case study of eight autopsies of pregnant women who died suddenly during childbirth by Clarence Lushbaugh and Paul Steiner enabled widespread recognition of the diagnosis within the medical community, and was eventually republished as a landmark paper in the Journal of the American Medical Association . [13] [14]

Related Research Articles

<span class="mw-page-title-main">Meconium aspiration syndrome</span> Medical condition affecting newborn infants

Meconium aspiration syndrome (MAS) also known as neonatal aspiration of meconium is a medical condition affecting newborn infants. It describes the spectrum of disorders and pathophysiology of newborns born in meconium-stained amniotic fluid (MSAF) and have meconium within their lungs. Therefore, MAS has a wide range of severity depending on what conditions and complications develop after parturition. Furthermore, the pathophysiology of MAS is multifactorial and extremely complex which is why it is the leading cause of morbidity and mortality in term infants.

<span class="mw-page-title-main">Amniocentesis</span> Sampling of amniotic fluid done mainly to detect fetal chromosomal abnormalities

Amniocentesis is a medical procedure used primarily in the prenatal diagnosis of genetic conditions. It has other uses such as in the assessment of infection and fetal lung maturity. Prenatal diagnostic testing, which includes amniocentesis, is necessary to conclusively diagnose the majority of genetic disorders, with amniocentesis being the gold-standard procedure after 15 weeks' gestation.

Fetal distress, also known as non-reassuring fetal status, is a condition during pregnancy or labor in which the fetus shows signs of inadequate oxygenation. Due to its imprecision, the term "fetal distress" has fallen out of use in American obstetrics. The term "non-reassuring fetal status" has largely replaced it. It is characterized by changes in fetal movement, growth, heart rate, and presence of meconium stained fluid.

<span class="mw-page-title-main">Umbilical cord prolapse</span> Complication of pregnancy where the umbilical cord slips out of the uterus prior to birth

Umbilical cord prolapse is when the umbilical cord comes out of the uterus with or before the presenting part of the baby. The concern with cord prolapse is that pressure on the cord from the baby will compromise blood flow to the baby. It usually occurs during labor but can occur anytime after the rupture of membranes.

Rupture of membranes (ROM) or amniorrhexis is a term used during pregnancy to describe a rupture of the amniotic sac. Normally, it occurs spontaneously at full term either during or at the beginning of labor. Rupture of the membranes is known colloquially as "breaking (one's) water," especially when induced rather than spontaneous, or as one's "water breaking". A premature rupture of membranes (PROM) is a rupture of the amnion that occurs at full term and prior to the onset of labor. In cases of PROM, options include expectant management without intervention, or interventions such as oxytocin or other methods of labor induction, and both are usually accompanied by close monitoring of maternal and fetal health. Preterm premature rupture of membranes (PPROM) is when water breaks both before the onset of labor and before the pregnancy's 37 week gestation. In the United States, more than 120,000 pregnancies per year are affected by a premature rupture of membranes, which is the cause of about one third of preterm deliveries.

<span class="mw-page-title-main">Placental abruption</span> Medical condition

Placental abruption is when the placenta separates early from the uterus, in other words separates before childbirth. It occurs most commonly around 25 weeks of pregnancy. Symptoms may include vaginal bleeding, lower abdominal pain, and dangerously low blood pressure. Complications for the mother can include disseminated intravascular coagulopathy and kidney failure. Complications for the baby can include fetal distress, low birthweight, preterm delivery, and stillbirth.

Bloody show or show is the passage of a small amount of blood or blood-tinged mucus through the vagina near the end of pregnancy. It is caused by thinning and dilation of the cervix, leading to detachment of the cervical mucus plug that seals the cervix during pregnancy and tearing of small cervical blood vessels, and is one of the signs that labor may be imminent. The bloody show may be expelled from the vagina in pieces or altogether and often appears as a jelly-like piece of mucus stained with blood. Although the bloody show may be alarming at first, it is not a concern of patient health after 37 weeks gestation.

<span class="mw-page-title-main">Hydrops fetalis</span> Human disease of fetuses

Hydrops fetalis or hydrops foetalis is a condition in the fetus characterized by an accumulation of fluid, or edema, in at least two fetal compartments. By comparison, hydrops allantois or hydrops amnion is an accumulation of excessive fluid in the allantoic or amniotic space, respectively.

<span class="mw-page-title-main">Prelabor rupture of membranes</span> Medical condition

Prelabor rupture of membranes (PROM), previously known as premature rupture of membranes, is breakage of the amniotic sac before the onset of labor. Women usually experience a painless gush or a steady leakage of fluid from the vagina. Complications in the baby may include premature birth, cord compression, and infection. Complications in the mother may include placental abruption and postpartum endometritis.

<span class="mw-page-title-main">Respiratory disease</span> Disease of the respiratory system

Respiratory diseases, or lung diseases, are pathological conditions affecting the organs and tissues that make gas exchange difficult in air-breathing animals. They include conditions of the respiratory tract including the trachea, bronchi, bronchioles, alveoli, pleurae, pleural cavity, the nerves and muscles of respiration. Respiratory diseases range from mild and self-limiting, such as the common cold, influenza, and pharyngitis to life-threatening diseases such as bacterial pneumonia, pulmonary embolism, tuberculosis, acute asthma, lung cancer, and severe acute respiratory syndromes, such as COVID-19. Respiratory diseases can be classified in many different ways, including by the organ or tissue involved, by the type and pattern of associated signs and symptoms, or by the cause of the disease.

<span class="mw-page-title-main">Chorioamnionitis</span> Medical condition

Chorioamnionitis, also known as intra-amniotic infection (IAI), is inflammation of the fetal membranes, usually due to bacterial infection. In 2015, a National Institute of Child Health and Human Development Workshop expert panel recommended use of the term "triple I" to address the heterogeneity of this disorder. The term triple I refers to intrauterine infection or inflammation or both and is defined by strict diagnostic criteria, but this terminology has not been commonly adopted although the criteria are used.

Postterm pregnancy is when a woman has not yet delivered her baby after 42 weeks of gestation, two weeks beyond the typical 40-week duration of pregnancy. Postmature births carry risks for both the mother and the baby, including fetal malnutrition, meconium aspiration syndrome, and stillbirths. After the 42nd week of gestation, the placenta, which supplies the baby with nutrients and oxygen from the mother, starts aging and will eventually fail. Postterm pregnancy is a reason to induce labor.

<span class="mw-page-title-main">Fetal warfarin syndrome</span> Congenital disorder caused by maternal warfarin administration

Fetal warfarin syndrome is a disorder of the embryo which occurs in a child whose mother took the medication warfarin during pregnancy. Resulting abnormalities include low birth weight, slower growth, intellectual disability, deafness, small head size, and malformed bones, cartilage, and joints.

<span class="mw-page-title-main">Velamentous cord insertion</span> Velamentous placenta

Velamentous cord insertion is a complication of pregnancy where the umbilical cord is inserted in the fetal membranes. It is a major cause of antepartum hemorrhage that leads to loss of fetal blood and associated with high perinatal mortality. In normal pregnancies, the umbilical cord inserts into the middle of the placental mass and is completely encased by the amniotic sac. The vessels are hence normally protected by Wharton's jelly, which prevents rupture during pregnancy and labor. In velamentous cord insertion, the vessels of the umbilical cord are improperly inserted in the chorioamniotic membrane, and hence the vessels traverse between the amnion and the chorion towards the placenta. Without Wharton's jelly protecting the vessels, the exposed vessels are susceptible to compression and rupture.

An obstetric labor complication is a difficulty or abnormality that arises during the process of labor or delivery.

Amnioinfusion is a method in which isotonic fluid is instilled into the uterine cavity.

Uterine Tachysystole is a condition of excessively frequent uterine contractions during pregnancy. It is most often seen in induced or augmented labor, though it can also occur during spontaneous labor, and this may result in fetal hypoxia and acidosis. This may have serious effects on both the mother and the fetus including hemorrhaging and death. There are still major gaps in understanding treatment as well as clinical outcomes of this condition. Uterine tachysystole is defined as more than 5 contractions in 10 minutes, averaged over a 30-minute period.

Hypertensive disease of pregnancy, also known as maternal hypertensive disorder, is a group of high blood pressure disorders that include preeclampsia, preeclampsia superimposed on chronic hypertension, gestational hypertension, and chronic hypertension.

<span class="mw-page-title-main">Emergency childbirth</span>

Emergency childbirth is the precipitous birth of an infant in an unexpected setting. In planned childbirth, mothers choose the location and obstetric team ahead of time. Options range from delivering at home, at a hospital, a medical facility or a birthing center. Sometimes, birth can occur on the way to these facilities, without a healthcare team. The rates of unplanned childbirth are low. If the birth is imminent, emergency measures may be needed. Emergency services can be contacted for help in some countries.

Anhydramnios is a condition in which there is an abnormally low or complete absence of amniotic fluid surrounding the fetus in the womb. Amniotic fluid is a clear, watery substance that surrounds the fetus. It helps to maintain a constant temperature around the fetus, cushion it from injury, and allows for proper fetal movement and organ development. The cause of anhydramnios is not always clear, but several factors can contribute to its development such as fetal renal abnormalities or placental insufficiency. Untreated anhydramnios can lead to serious complications for the baby, including pulmonary hypoplasia or skeletal deformities.

References

  1. ↑ Stafford, Irene; Sheffield, Jeanne (2007). "Amniotic Fluid Embolism". Obstetrics and Gynecology Clinics of North America. 34 (3): 545–553. doi:10.1016/j.ogc.2007.08.002. ISSN   0889-8545. PMID   17921014. S2CID   30754268.[subscription required]
  2. 1 2 Stein, Paul (2016). Pulmonary embolism. Chichester, West Sussex, UK Hoboken, NJ: John Wiley & Sons Inc. ISBN   9781119039099.
  3. ↑
    • Leveno, Kenneth (2016). Williams manual of pregnancy complications. New York: McGraw-Hill Medical. pp. 223–224. ISBN   9780071765626.
  4. 1 2 3 4 5 6 7 8 9 10 Knight, Marian; Berg, Cynthia; Brocklehurst, Peter; Kramer, Michael; Lewis, Gwyneth; Oats, Jeremy; Roberts, Christine L; Spong, Catherine; Sullivan, Elizabeth; van Roosmalen, Jos; Zwart, Joost (2012-02-10). "Amniotic fluid embolism incidence, risk factors and outcomes: a review and recommendations". BMC Pregnancy and Childbirth. 12: 7. doi: 10.1186/1471-2393-12-7 . ISSN   1471-2393. PMC   3305555 . PMID   22325370.
  5. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 Kaur, Kiranpreet; Bhardwaj, Mamta; Kumar, Prashant; Singhal, Suresh; Singh, Tarandeep; Hooda, Sarla (2016). "Amniotic fluid embolism". Journal of Anaesthesiology Clinical Pharmacology. 32 (2): 153–159. doi: 10.4103/0970-9185.173356 . ISSN   0970-9185. PMC   4874066 . PMID   27275041.
  6. 1 2 3 4 5 6 7 8 9 Stafford, Irene A.; Moaddab, Amirhossein; Dildy, Gary A.; Klassen, Miranda; Berra, Alexandra; Watters, Christine; Belfort, Michael A.; Romero, Roberto; Clark, Steven L. (May 2020). "Amniotic fluid embolism syndrome: analysis of the United States International Registry". American Journal of Obstetrics & Gynecology MFM. 2 (2): 100083. doi:10.1016/j.ajogmf.2019.100083. ISSN   2589-9333. PMC   8500673 . PMID   33345954.
  7. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Gist, Richard S.; Stafford, Irene P.; Leibowitz, Andrew B.; Beilin, Yaakov (May 2009). "Amniotic Fluid Embolism". Anesthesia & Analgesia. 108 (5): 1599–2102. doi:10.1213/ane.0b013e31819e43a4. ISSN   0003-2999. PMID   19372342. S2CID   12588882.
  8. 1 2 3 4 5 6 7 8 9 10 Suvannasarn, R.; Tongsong, T.; Jatavan, P. (2020-04-15). "Amniotic fluid embolism: the pathophysiology, diagnostic clue, and blood biomarkers indicator for disease prediction". Clinical and Experimental Obstetrics & Gynecology. 47 (2): 159–165. doi: 10.31083/j.ceog.2020.02.5176 . ISSN   0390-6663. S2CID   219666490.
  9. ↑ Baxter, Frederick, MD, CCFP, Whippey, Amanda, MD, FRCPC. Amniotic Fluid Embolism Treated With Inhaled Milrinone: A Case Report. A A Pract. 2020;14(13):e01342. doi:10.1213/XAA.0000000000001342.
  10. ↑ Gebhard CE, Rochon A, Cogan J, et al. Acute right ventricular failure in cardiac surgery during cardiopulmonary bypass separation: a retrospective case series of 12 years' experience with intratracheal milrinone administration. J Cardiothorac Vasc Anesth. 2019; 33:651-660
  11. ↑ Sablotzki A, Starzmann W, Scheubel R, Grond S, Czeslick EG. Selective pulmonary vasodilation with inhaled aerosolized milrinone in heart transplant candidates. Can J Anaesth. 2005; 52:1076-1082
  12. ↑ "CEArticlePrint". nursingcenter.com. Retrieved 2021-02-25.
  13. 1 2 Caeiro, Ana Filipa Cabrita; Ramilo, Irina Dulce Tapadinhas Matos; Santos, Ana Paula; Ferreira, Elizabeth; Batalha, Isabel Santos (July 2017). "Amniotic Fluid Embolism. Is a New Pregnancy Possible? Case Report". Brazilian Journal of Gynecology and Obstetrics. 39 (7): 369–372. doi: 10.1055/s-0037-1601428 . PMC   10416167 . PMID   28464190.
  14. ↑ Steiner, Paul E.; Lushbaugh, Clarence C. (October 11, 1941). "Landmark article, Oct. 1941: Maternal pulmonary embolism by amniotic fluid as a cause of obstetric shock and unexpected deaths in obstetrics". Journal of the American Medical Association. 255 (16): 2187–2303. doi:10.1001/jama.255.16.2187. PMID   3514978 – via PubMed.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.